Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
Wagner J, Kline CL, Zhou L, Campbell KS, MacFarlane AW, Olszanski AJ, Cai KQ, Hensley HH, Ross EA, Ralff MD, Zloza A, Chesson CB, Newman JH, Kaufman H, Bertino J, Stein M, El-Deiry WS. Wagner J, et al. Among authors: zloza a. J Clin Invest. 2018 Jun 1;128(6):2325-2338. doi: 10.1172/JCI96711. Epub 2018 Apr 30. J Clin Invest. 2018. PMID: 29533922 Free PMC article.
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.
Kohlhapp FJ, Broucek JR, Hughes T, Huelsmann EJ, Lusciks J, Zayas JP, Dolubizno H, Fleetwood VA, Grin A, Hill GE, Poshepny JL, Nabatiyan A, Ruby CE, Snook JD, Rudra JS, Schenkel JM, Masopust D, Zloza A, Kaufman HL. Kohlhapp FJ, et al. Among authors: zloza a. J Immunother Cancer. 2015 May 19;3:18. doi: 10.1186/s40425-015-0063-3. eCollection 2015. J Immunother Cancer. 2015. PMID: 25992289 Free PMC article.
Oncolytic viruses: a new class of immunotherapy drugs.
Kaufman HL, Kohlhapp FJ, Zloza A. Kaufman HL, et al. Among authors: zloza a. Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663. Nat Rev Drug Discov. 2015. PMID: 26323545 Free PMC article. Review.
Talimogene laherparepvec (T-VEC) as cancer immunotherapy.
Kohlhapp FJ, Zloza A, Kaufman HL. Kohlhapp FJ, et al. Among authors: zloza a. Drugs Today (Barc). 2015 Sep;51(9):549-58. doi: 10.1358/dot.2015.51.9.2383044. Drugs Today (Barc). 2015. PMID: 26488034 Review.
73 results